This contract expires in 380 days (Sep 27, 2027).

Browse related active opportunities

COST NO FEE

DUKE UNIVERSITY - BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS

PIID: 75N94023F00004
Signed Date: Jan 23, 2026Effective Date: Sep 28, 2023End Date: Closes in 380 days
Award $
$8.8M
Vendor
DUKE UNIVERSITY
NAICS
541715
Signed Date
Jan 23, 2026

Key Details

Dollars Obligated
$8.8M
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
DURHAM, NC, 277054677, CD-NC-04

Description

BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS

Context & Analysis

On Jan 23, 2026, Department of Health and Human Services obligated $8,783,682 to DUKE UNIVERSITY for bpca innovative trial designs and assay developments in pediatric therapeutics. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Sep 27, 2027 — approximately 13 months remaining.

Contractor Information

Contractor: DUKE UNIVERSITY
UEI: TP7EK8DZV6N5
CAGE Code: 4B478
Location: DURHAM, NC
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related